Literature DB >> 36002687

Laparoscopic pancreatic enucleation: cystic lesions and proximity to the Wirsung duct increase postoperative pancreatic fistula.

Béatrice Aussilhou1, Fadhel Samir Ftériche1, Morgane Bouquot1,2, Mickael Lesurtel1,2, Alain Sauvanet1,2, Safi Dokmak3.   

Abstract

BACKGROUND: Risk factors for postoperative pancreatic fistula (POPF) following pancreatic enucleation by the open approach (OpenEN) are well known. However, ENs are more frequently performed laparoscopically (LapEN). The aim of this study was to analyze the risk factors of POPF following LapEN. METHODS AND PATIENTS: All patients in our prospective database who underwent LapEN were evaluated. We report the demographics, surgical, early and long-term outcomes. Numerous variables were analyzed to identify the risk factors of POPF.
RESULTS: From 2008 to 2020, 650 laparoscopic pancreatic resections were performed including 64 EN (10%). The median age was 51 years old (17-79), median BMI was 24 (19-48), and 44 patients were women (69%). The main presentation was an incidental diagnosis (n = 40; 62%), pain (n= 10;16%), and hypoglycemia (n = 8;12%). The main indications were neuroendocrine tumors (40; 63%), mucinous cystadenomas (15; 23%), intraductal papillary mucinous neoplasie (3; 5%), and other benign cysts (6; 9%). Lesions were located on the distal pancreas (43; 67%), head (n = 17; 27%), and neck (4; 6%). The median size was 20 mm (9-110); 30 mm (20-110) for mucinous cystadenoma and 18 mm (8-33) for NET. The median operative time was 90 mn (30-330), median blood loss was 20 ml (0-800) ml, and there were no transfusions and one conversion. There were no mortalities and overall morbidity (n = 22; 34%) included grades B and C POPF (10;16%) and post-pancreatectomy hemorrhage (4; 6%). The median hospital stay was 7 days (3-42). There were no invaded lymph nodes and all cystic lesions were nonmalignant. After a mean follow-up of 24 months, there was no recurrence. The risk factors for grades B/C POPF were mucinous cystadenoma and proximity to the Wirsung duct < 3 mm.
CONCLUSION: In this series, the outcome of LapEN was excellent with no mortality and a low rate of morbidity. However, the risk of POPF is increased with cystic lesions and those close to the Wirsung duct.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Enucleation; Laparoscopic approach; Laparoscopy; Minimally invasive approach; Parenchymal sparing surgery

Year:  2022        PMID: 36002687     DOI: 10.1007/s00464-022-09527-w

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  27 in total

Review 1.  Laparoscopic parenchyma-sparing pancreatectomy.

Authors:  Tamotsu Kuroki; Susumu Eguchi
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-09-11       Impact factor: 7.027

2.  Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis.

Authors:  Tommaso Giuliani; Matteo De Pastena; Salvatore Paiella; Giovanni Marchegiani; Luca Landoni; Michele Festini; Marco Ramera; Veronica Marinelli; Luca Casetti; Alessandro Esposito; Claudio Bassi; Roberto Salvia
Journal:  Ann Surg       Date:  2021-04-14       Impact factor: 12.969

Review 3.  Meta-analysis of surgical outcome after enucleation versus standard resection for pancreatic neoplasms.

Authors:  F J Hüttner; J Koessler-Ebs; T Hackert; A Ulrich; M W Büchler; M K Diener
Journal:  Br J Surg       Date:  2015-06-04       Impact factor: 6.939

4.  Propensity score-matched analysis of clinical outcome after enucleation versus regular pancreatectomy in patients with small non-functional pancreatic neuroendocrine tumors.

Authors:  Mao Weilin; Han Xu; Lv Yang; Chen Wenqi; Wang Huanyu; Zhou Wentao; Jin Dayong; Wu Wenchuan; Wang Dansong; Kuang Tiantao; Zhang Lei; Lou Wenhui; Xu Xuefeng
Journal:  Pancreatology       Date:  2020-01-03       Impact factor: 3.996

5.  Pancreatic enucleation: improved outcomes compared to resection.

Authors:  C E Cauley; H A Pitt; K M Ziegler; A Nakeeb; C M Schmidt; N J Zyromski; M G House; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2012-04-24       Impact factor: 3.452

6.  Increased rate of clinically relevant pancreatic fistula after deep enucleation of small pancreatic tumors.

Authors:  Kristin Heeger; Massimo Falconi; Stefano Partelli; Jens Waldmann; Stefano Crippa; Volker Fendrich; Detlef K Bartsch
Journal:  Langenbecks Arch Surg       Date:  2014-02-14       Impact factor: 3.445

7.  Role of laparoscopic enucleation in the treatment of pancreatic lesions: case series and case-matched analysis.

Authors:  Mushegh A Sahakyan; Bård Ingvald Røsok; Airazat M Kazaryan; Leonid Barkhatov; Sven-Petter Haugvik; Åsmund Avdem Fretland; Dejan Ignjatovic; Knut Jørgen Labori; Bjørn Edwin
Journal:  Surg Endosc       Date:  2016-09-12       Impact factor: 4.584

8.  Enucleation of pancreatic neoplasms.

Authors:  S Crippa; C Bassi; R Salvia; M Falconi; G Butturini; P Pederzoli
Journal:  Br J Surg       Date:  2007-10       Impact factor: 6.939

9.  Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate?

Authors:  Susan C Pitt; Henry A Pitt; Marshall S Baker; Kathleen Christians; John G Touzios; James M Kiely; Sharon M Weber; Stuart D Wilson; Thomas J Howard; Mark S Talamonti; Layton F Rikkers
Journal:  J Gastrointest Surg       Date:  2009-06-23       Impact factor: 3.452

10.  Parenchyma-sparing pancreatectomy for presumed noninvasive intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Alain Sauvanet; Sébastien Gaujoux; Benjamin Blanc; Anne Couvelard; Safi Dokmak; Marie-Pierre Vullierme; Philippe Ruszniewski; Jacques Belghiti; Philippe Lévy
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.